Print this page    •   Back to Web version of article

Webinar "Draft Guidance Vaginal Microbicides: Development for the Prevention of HIV Infection"

January 17, 2013

On Tuesday, January 22, 2013, from 2:00 - 3:00PM (ET), FDA will present a webinar to discuss the recently published draft guidance for industry entitled, "FDA Guidance for Industry Webinar on Draft Guidance Vaginal Microbicides: Development for the Prevention of HIV Infection"


This webinar will focus on select sections of the guidance including:

Other topics that will be covered in brief include non-clinical development considerations and approaches to combination product development. The webinar is intended to provide developers, industry, and academia an overview of key issues discussed in this draft FDA guidance.

Instructions for online access to the webinar :

To access this webinar, follow the link provided below. Audio will broadcast from your computer speakers. After following the link, enter as a guest and provide your FULL NAME and organization (i.e. "John Smith - FDA/CBER"). The host will then allow you to enter. If you experience technical difficulties email for assistance.

Closed captioning will be provided.

Questions/Comments can be submitted live via a Q/A chat window during the webinar.

Webinar Access link:


Federal Register Notice

Draft Guidance For Industry on Vaginal Microbicides: Development for the Prevention of HIV Infection

If you have never attended a Connect Pro meeting before, please test your connection before the lecture by following this link:

This article was provided by U.S. Food and Drug Administration. You can find this article online by typing this address into your Web browser:

General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.